Fundraising Fox
Biosynthetic Technologies
Irvine, US · Founded 2010 · 7 known investors
Find your way into Biosynthetic Technologies
Sign up to see every warm intro you have to Biosynthetic Technologies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Biosynthetic Technologies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Biosynthetic Technologies develops innovative solutions in R&D and operations for sustainability-focused applications. The company serves markets requiring supply chain and operational expertise.
Founders & leadership
Board
Investors · 7
How we know: HG Ventures's portfolio page · a partner's Signal profile · funding news · prnewswire.com · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: press coverage · Not right? Tell us
Funding
SEC filings, press & company announcements$28.5M disclosed across 2 of 3 rounds · 2014–2022
- Undisclosed amountseries A-1Feb 2022
HG Ventures (lead)
Source ↗
▶$16.5MraisedFeb 2017 · 5 investors · ManufacturingRule 506(b)
- Bernhard MohrDirector
- Meghan SharpDirector
- Allen BarbieriExecutive Officer, Director
- Kent WassonDirector
- Steve BierschenkDirector
- John HopkinsDirector
- Gerald KohlenbergerDirector
- Offering amount
- $28M
- Amount sold
- $16.5M
- First sale
- Dec 2016
- Incorporated
- Limited Liability Company, Montana
- Federal exemptions
- 06b
▶$12MraisedOct 2014 · 3 investors · ManufacturingRule 506(b)
- Steven BierschenkDirector
- John HopkinsDirector
- Bernhard MohrDirector
- Kent WassonDirector
- Gerald KohlenbergerDirector
- Allen BarbieriExecutive Officer, Director
- Meghan SharpDirector
- Offering amount
- $12M
- Amount sold
- $12M
- First sale
- May 2014
- Incorporated
- Limited Liability Company, California, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Biosynthetic Technologies do?
- Biosynthetic Technologies develops innovative solutions in R&D and operations for sustainability-focused applications. The company serves markets requiring supply chain and operational expertise.
- Who are Biosynthetic Technologies's investors?
- Biosynthetic Technologies's investors include HG Ventures, Athos, Civilization Ventures Management, Llc, Global Health Investment Corporation, In-Q-Tel, Sherpalo Ventures, Viking Global Investors.
- How much funding has Biosynthetic Technologies raised?
- Biosynthetic Technologies has disclosed $28.5M raised across 2 of its 3 known rounds.
- Where is Biosynthetic Technologies headquartered?
- Biosynthetic Technologies is headquartered in Irvine, US.